Dr. Moataz Ahmed Shaldam

Assistant Professor of Pharmaceutical Chemistry

Department of Pharmaceutical Chemistry, Faculty of Pharmacy,Kafrelsheikh University, Egypt

Google ScholarORCIDResearchGateEmail

Dr. Moataz Ahmed Shaldam is an Assistant Professor of Pharmaceutical Chemistry.His research focuses on computer-aided drug design, medicinal chemistry,anticancer drug discovery, enzyme inhibitors, anti-infective agents,quorum sensing inhibitors, and molecular modeling.

• Computer-Aided Drug Design (CADD)
• Molecular Docking
• Virtual Screening
• Molecular Dynamics Simulations
• Medicinal Chemistry
• Drug Discovery and Lead Optimization
• Carbonic Anhydrase Inhibitors
• VEGFR-2 Inhibitors
• Anticancer Agents
• Quorum Sensing Inhibitors
• Anti-Virulence Drug Discovery

Journal of Medicinal Chemistry (2024)
Discovery and mechanistic studies of dual-target hits forcarbonic anhydrase IX and VEGFR-2 as potential agents for solid tumors.

Journal of Medicinal Chemistry (2023)
1,5-Diaryl-1,2,4-triazole ureas as new SLC-0111 analogues endowed with dual carbonic anhydrase and VEGFR-2 inhibitory activities.

Journal of Enzyme Inhibition and Medicinal Chemistry (2023)
Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors.

European Journal of Clinical Microbiology & Infectious Diseases (2020)
Drugs with new lease of life as quorum sensing inhibitors for combating MDR Acinetobacter baumannii infections.

View Full Google Scholar Profile

• Medicinal Chemistry
• Computer-Aided Drug Design
• Drug Discovery
• Pharmaceutical Chemistry
• Molecular Modeling
• Chemoinformatics